JP2013503880A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503880A5
JP2013503880A5 JP2012528002A JP2012528002A JP2013503880A5 JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5 JP 2012528002 A JP2012528002 A JP 2012528002A JP 2012528002 A JP2012528002 A JP 2012528002A JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutical composition
group
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012528002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503880A (ja
JP5653438B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047488 external-priority patent/WO2011028775A1/en
Publication of JP2013503880A publication Critical patent/JP2013503880A/ja
Publication of JP2013503880A5 publication Critical patent/JP2013503880A5/ja
Application granted granted Critical
Publication of JP5653438B2 publication Critical patent/JP5653438B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012528002A 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法 Expired - Fee Related JP5653438B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US27225409P 2009-09-04 2009-09-04
US61/272,254 2009-09-04
US28250810P 2010-02-22 2010-02-22
US61/282,508 2010-02-22
US35393510P 2010-06-11 2010-06-11
US61/353,935 2010-06-11
PCT/US2010/047488 WO2011028775A1 (en) 2009-09-04 2010-09-01 Methods of treating orthomyxoviral infections

Publications (3)

Publication Number Publication Date
JP2013503880A JP2013503880A (ja) 2013-02-04
JP2013503880A5 true JP2013503880A5 (cg-RX-API-DMAC7.html) 2014-03-20
JP5653438B2 JP5653438B2 (ja) 2015-01-14

Family

ID=43649616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528002A Expired - Fee Related JP5653438B2 (ja) 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法

Country Status (12)

Country Link
US (2) US20110065752A1 (cg-RX-API-DMAC7.html)
EP (1) EP2473482B1 (cg-RX-API-DMAC7.html)
JP (1) JP5653438B2 (cg-RX-API-DMAC7.html)
KR (1) KR101497194B1 (cg-RX-API-DMAC7.html)
CN (1) CN102625796B (cg-RX-API-DMAC7.html)
BR (1) BR112012004676A2 (cg-RX-API-DMAC7.html)
CA (1) CA2772875A1 (cg-RX-API-DMAC7.html)
DK (1) DK2473482T3 (cg-RX-API-DMAC7.html)
ES (1) ES2466027T3 (cg-RX-API-DMAC7.html)
MX (1) MX2012002486A (cg-RX-API-DMAC7.html)
PL (1) PL2473482T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011028775A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2579628T3 (es) 2009-02-23 2016-08-12 Emergent Virology Llc Iminoazúcares y métodos de tratamiento de enfermedades virales
CA2875975A1 (en) 2012-06-06 2013-12-12 Unither Virology, Llc Novel iminosugars and their applications
CA2924026C (en) * 2013-09-16 2021-12-28 Emergent Virology Llc Deoxynojirimycin derivatives and methods of their using
CA2966893C (en) 2014-11-05 2023-10-24 Emergent Virology Llc Iminosugars
WO2017201030A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating viral infection
EP3934688A4 (en) * 2019-03-08 2022-12-21 University of Virginia Patent Foundation COMPOSITIONS AND METHODS FOR MODULATION OF VIRAL INFECTION THROUGH REGULATION OF GLUCOSYLCERAMIDS
CN111904959A (zh) * 2020-08-21 2020-11-10 牡丹江医学院 α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途
IT202200007808A1 (it) * 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
CN119841765B (zh) * 2025-01-09 2025-10-10 中南大学 Dnj衍生物、药物组合物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013A (en) * 1851-04-01 Improvement in wheat-fans
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
AU761748B2 (en) * 1997-12-11 2003-06-12 Chancellor, Masters And Scholars Of The University Of Oxford, The Inhibition of membrane-associated viral replication
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
ES2311921T3 (es) * 1999-02-12 2009-02-16 United Therapeutics Corporation N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP2003505430A (ja) * 1999-07-26 2003-02-12 ジー・ディー・サール・アンド・カンパニー デオキシノジリマイシンの長鎖n−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
DE60037664T2 (de) * 1999-08-10 2008-12-24 The Chancellor, Masters And Scholars Of The University Of Oxford Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
JP5589165B2 (ja) * 2003-01-31 2014-09-17 マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー タンパク質欠損性障害の治療のための併用療法
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
CA2601797A1 (en) * 2005-03-16 2006-09-21 University Of Oxford Mannose immunogens for hiv-1
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
BRPI0615974A2 (pt) * 2005-07-27 2011-05-31 University Of Florida Research Foundation, Inc., uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular
CN101267779A (zh) * 2005-07-27 2008-09-17 福罗里达大学研究基金会有限公司 使用热休克治疗眼睛疾病
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
DE602007008870D1 (de) * 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
CN101489554A (zh) * 2006-05-24 2009-07-22 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
CN102727437A (zh) * 2006-08-02 2012-10-17 牛津大学院长校长专家委员会 病毒感染的脂质体治疗
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
CN101172127B (zh) * 2006-10-31 2011-12-07 上海市新文达生物科技有限公司 一种桑叶提取物及其在制备抗甲型流感病毒药物中的应用
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CN101278977B (zh) * 2008-03-31 2012-05-30 广州唐百服生物科技有限公司 一种桑叶主要活性成分的提取方法及其提取物用途

Similar Documents

Publication Publication Date Title
CN110325187B (zh) N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2009535352A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2013503881A5 (cg-RX-API-DMAC7.html)
JP2009501732A5 (cg-RX-API-DMAC7.html)
JP2014515351A5 (cg-RX-API-DMAC7.html)
JP2013516450A5 (cg-RX-API-DMAC7.html)
JP2018021051A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
JP2016504284A5 (cg-RX-API-DMAC7.html)
JP2010501584A5 (cg-RX-API-DMAC7.html)
WO2011000566A3 (en) Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
JP2012518649A5 (cg-RX-API-DMAC7.html)
JP2009536660A5 (cg-RX-API-DMAC7.html)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
CO6571891A2 (es) Inhibidores del virus de la hepatitis c.
NZ598208A (en) Inhibitors of flaviviridae viruses
WO2008089125A2 (en) Antiviral compounds and methods of using thereof
JP2013503882A5 (cg-RX-API-DMAC7.html)
RU2016111704A (ru) Производные дезоксинойиримицина и способы их применения
JP2013542992A5 (cg-RX-API-DMAC7.html)
JP2013542981A5 (cg-RX-API-DMAC7.html)
JP5653438B2 (ja) オルトミクソウイルス感染の治療方法
JP2016537432A5 (cg-RX-API-DMAC7.html)